Introduction to Veterinary Pharmacovigilance

A basic training course for those working on drug safety in the EU. This course has been designed to provide basic training and a good introduction to those concerned with veterinary pharmacovigilance.

INCLUDES: Interactive workshop and discussion sessions

5-6 May 2020

& 14-15 Oct 2020

GBP 1,399 1,199 *
EUR 1,959 1,679 *
USD 2,182 1,870 *
* When you book before 10 Apr

Book now

Course Overview

This two-day event has been designed to provide an essential overview of veterinary pharmacovigilance and will offer practical guidance and basic training for all those working in drug safety in the EU.

Our experienced trainer will clarify roles and responsibilities, explain commonly used terminology and take participants through all the key aspects of this complex subject. There will be plenty of time for interaction and questions and answers to enable participants to get a good understanding of the issues involved. The use of industry case studies will demonstrate real-life scenarios to help embed learning.

Benefits of attending:

  • Gain an overview of the European regulatory framework
  • Be aware of Volume IXb
  • Learn about VICH
  • Understand adverse event reporting
  • Hear about causality assessment
  • Minimise the impact of data with errors
  • Know the requirements for periodic safety update reports (PSURs)
  • Get to grips with literature searches
  • Understand the implications of the proposed EU pharmacovigilance legislation and Brexit

Who should attend?

The course will be beneficial to those new to veterinary pharmacovigilance, support staff and experienced personnel who require a better understanding of drug safety in their current role. Adverse event monitoring and drug safety officers, together with regulatory affairs and personnel from registration departments, will also find this seminar useful.

Programme

DAY ONE

What is pharmacovigilance?

  • Beneficial and harmful effects of veterinary medicinal products
  • Key definitions

The current regulatory framework and its global impact

  • Overview of European regulatory framework, including Volume IXB and implications of the proposed EU pharmacovigilance legislation
  • Implications for global environment – link to VICH
  • Practical applications of definitions

Adverse event reporting

  • Definitions
  • Impact of VICH guidelines
  • Expedited vs periodic
  • How to handle animal SARs
  • Handling human SARs
  • Understanding the wider scope of pharmacovigilance

Causality assessment

  • The principles of causality assessment with practical examples
  • Medical evaluation of individual reports of adverse events
  • Strategies for follow-up

Pharmacovigilance case studies

DAY TWO

Electronic communication in pharmacovigilance

  • Reporting in EV Vet
  • VEDDRA

Minimising the impact of data with errors

  • Consistent assessment and coding

Clinical trial AE reporting requirements

  • Post-authorisation safety studies
  • Phase IV studies

Literature searches

  • Peer-reviewed worldwide literature
  • Local journals and magazines
PSURs
  • Format and content of the PSUR
  • Analysis of data
  • Incidence calculation
  • Compliance and the PSUR
  • Addendum reports
  • Bridging reports

Practical workshop on PSURs

Discussion sessions will take place throughout the two days

Presenter

Declan O'Rourke

Declan O’Rourke has over 20 years’ experience in industry where he has held technical, marketing, product development, clinical development, production and pharmacovigilance roles.

Declan is a veterinary surgeon, holds a Diploma in Marketing, a Master of Business Administration and a Fellowship of the Royal College of Veterinary Surgeons. He now directs Ortec Consultancy specialising in EU pharmacovigilance and represented IFAH-EU in the VICH Working Group on pharmacovigilance.

Declan is also an Honarary Associate Professor in Veterinary Pharmaceutical Development at Nottingham Veterinary School, Past President of British Cattle Veterinary Association and a member of the Veterinary Products Committee (VPC).

Book now

5-6 May 2020
5-6 May 2020 Rembrandt Hotel, London GBP 1,399.00
EUR 1,959.00
USD 2,182.00
+ VAT @ 20.00%
GBP 1,199.00
EUR 1,679.00
USD 1,870.00
Until 10 Apr*
Enrol now
14-15 Oct 2020
14-15 Oct 2020 Rembrandt Hotel, London GBP 1,399.00
EUR 1,959.00
USD 2,182.00
+ VAT @ 20.00%
Enrol now

* Note the early booking discount cannot be combined with any other offers or promotional code

You may also be interested in

Previous customers include...

  • ACD Pharmaceuticals
  • Animlacare
  • Bayer
  • Beaphar BV
  • Benchmark Animal Health
  • Boehringer Ingelheim RCV GmbH & Co KG
  • Cyton Biosciences Ltd
  • DADA Consultancy BV
  • Dechra Veterinary Products Deutschland GmbH
  • DR. E. GRAEUB AG
  • Eco Animal Health Group plc
  • Greveling Holding BV
  • Grovet BV
  • Huvepharma
  • Huvepharma NV
  • Jacobsen Pharma & MedTech Advice A/S
  • MERIAL- GROUPE BOEHRINGER INGELHEIM
  • Norbrook Laboratories Ltd
  • Pharmacosmos
  • Pharmacovigilance Matters Limited
  • Pharmaxim AB
  • Scanvacc AS
  • Seacalx AS
  • SSCL Animal and Plant Health Agency
  • TBC
  • Triveritas Limited
  • Versele-Laga
  • Vetcare Oy
  • Veterinary Medicines Directorate
  • Zoetis Deutschland GmbH

A good course to get a general introduction to Veterinary Pharmacovigilance, for those new to pharmacovigilance. The speaker, Declan O'Rourke, is very experienced and very enthusiastic in his presentation.

Anders Hessellund Bisgaard, QA & RA Assistant, Salfarm Danmark A/S

In general very interesting course.

Guy Werquin, Veterinary Doctor, Versele-Laga

[The speaker was] enthusiastic, clear and easy to understand. The material was relevant and well explained.

Donal Donnelly, Clinical Veterinary Surgeon and Deputy QPPV, Norbrook Laboratories Ltd

Good general overview about pharmacovigilance. Talented and passionate speaker. Many practical examples.

Tom Decock, Regulatory Affairs, Versele-Laga

Very good course. Personally I would have needed more time on PSURs and signal detection and less on cases assessment. Very informative and enthusiastic.

Claire Milard, Pharmacovigilance manager, Merial - Boehringer Ingelheim

Well updated, easy to understand for a person with non-english mother tongue.

Lars Speilberg, Manager R&D, Scanvacc AS

Enjoyed method of presenting.

Lisa Glen, Project Manager, Benchmark Animal Health

interesting, experienced speaker, great overview of pharmacovigilance.

Karen Roels, Clinical Trial Manager, Huvepharma NV

Very good

Luciano Gobbi, Associate Director Regulatory Affairs, MSD Animal Health SRL

Structured, logical and critical approach to a complex case handling.

Maud Christelle Ricatti, DVM, ACD Pharmaceuticals

Very good

Felicity Caddick, veterinary technical advisor, Animlacare

Interesting and informative course. Enthusiastic and informative speaker.

Hannah Robbins, Pharmacovigilance VRO, Veterinary Medicines Directorate

Overall I was very impressed with the course

Lee Smith, Pharmacovigilance E9O, Veterinary Medicines Directorate

I think that this course is great for people looking for more insight into pharmacovigilance and would recommend it

Jamie Jardine, Administrative Officer, Veterinary Medicines Directorate

Very interesting program, well organized, with a very experienced speaker, with good presentation technique and with a good ability to capture the interest of the participants. the presentations were clear and interesting.

Marlene Delgado, QPPV, ZOOPAN S.A.

Relevant, good course

Katrine Underlien, Drug Safety Coordinator, Pharmacosmos

Good knowledge sharing, open dialogue, not all slides in the binder up to date, overall very positive

Angela van der Salm, Director Pharmacovigilance, DADA Consultancy